En esta página
BDTX Black Diamond Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 5, 2026
$1,89
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,60mínimo 52 semanas
$4,94máximo 52 semanas
Capitalización Bursátil (MRQ)
$109M
P/E (TTM)
-2.6
BPA (TTM)
$-0.73
Ingresos (TTM)
$0
tus insignias
Rango 52S
$2–$5
Calificación del Analista
BUY
Precio Objetivo
$10
P/E
-2.6
ROE
-37.2%
Margen de Beneficio Neto
31.9%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
BDTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.89
Capitalización Bursátil (MRQ)
$109M
P/E (TTM)
-2.6
BPA (TTM)
$-0.73
Ingresos (TTM)
$0
ROE (TTM)
-37.2%
Rango 52S
$2–$5
BDTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$70M2018-12-31 → 2025-12-31
BPA$0.392020-12-31 → 2025-12-31
Flujo de caja libre·2019-12-31 → 2024-12-31
Margen neto31.9%2025-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | BDTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.6promedio 5A ≈0.2 | ≈0.2 | · | · | |
| P/S | 1.5 | · | 17.2 | Infravalorado | |
| P/C (MRQ) | 1.1promedio 5A ≈1.1 | ≈1.1 | 1.7 | Infravalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | 3.7promedio 5A ≈-0.4 | ≈-0.4 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.0promedio 5A ≈1.1 | ≈1.1 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | BDTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | 17.9% | · | -1088.2% | De primer nivel | |
| EBITDA Margin (Margen EBITDA) | 17.9% | · | -1088.2% | De primer nivel | |
| Net Profit Margin (Margen de Beneficio Neto) | 31.9% | · | -988.2% | De primer nivel | |
| ROA (TTM) | -29.2%promedio 5A ≈-34.7% | ≈-34.7% | -50.5% | De primer nivel | |
| ROE (TTM) | -37.2%promedio 5A ≈-51.7% | ≈-51.7% | -88.6% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | BDTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 7.3promedio 5A ≈7.5 | ≈7.5 | 7.5 | En línea | |
| Quick Ratio (Ratio Rápido) | 1.3promedio 5A ≈2.2 | ≈2.2 | 4.9 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | BDTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.5 | · | 0.0 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$3.3M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
639.8%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 6, 2026 | $-0.17 | $-0.20 | 14.7% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.16 | $-0.19 | 15.1% |
| 31 de diciembre de 2025 | $-0.27 | $-0.19 | -42.1% | |
| 30 de septiembre de 2025 | $-0.15 | $-0.24 | 37.3% | |
| 30 de junio de 2025 | $-0.19 | $-0.25 | 24.5% | |
| 31 de marzo de 2025 | $0.98 | $0.02 | 4416.1% | |
| 31 de diciembre de 2024 | $-0.28 | $-0.32 | 12.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $34M | $51M | $59M | $64M | $97M | $48M | $22M | $7M | |
| SG&A Expense | $17M | $27M | $27M | $28M | $30M | $21M | $8M | $2M | |
| Operating Expenses | $57M | $79M | $86M | $93M | $127M | $70M | $29M | $9M | |
| Operating Income | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | $-9M | |
| Interest Expense | · | · | · | · | $0 | $1.0K | $0 | · | |
| Other Non-op | $6M | $7M | $2M | $-354.0K | $-2M | $-2M | $6.0K | $-16.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | $-9M | |
| EPS (Basic) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| EPS (Diluted) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| Shares (Basic) | 56,868,111 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| Shares (Diluted) | 57,562,746 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| EBITDA | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $36M | $56M | $34M | $66M | $35M | $155M | $52M | |
| Prepaid Expense | $4M | $3M | $3M | $5M | $6M | $4M | $1M | $24.0K | |
| Current Assets | $132M | $101M | $134M | $128M | $216M | $320M | $156M | $52M | |
| PP&E (Net) | $365.0K | $1M | $2M | $3M | $3M | $385.0K | $164.0K | $134.0K | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $3M | $549.0K | $276.0K | $234.0K | |
| Accum. Depreciation | $1M | $1M | $799.0K | $750.0K | $369.0K | $164.0K | $112.0K | $100.0K | |
| Other Non-current Assets | $73.0K | $249.0K | $0 | $0 | $16.0K | $106.0K | $59.0K | $8.0K | |
| Total Assets | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Accounts Payable | $579.0K | $4M | $2M | $2M | $4M | $3M | $2M | $416.0K | |
| Accrued Liabilities | $15M | $17M | $17M | $13M | $20M | $12M | $3M | $452.0K | |
| Current Liabilities | $16M | $21M | $20M | $15M | $24M | $14M | $5M | $3M | |
| Capital Leases | $15M | $19M | $22M | $25M | $28M | $8M | · | · | |
| Total Liabilities | $31M | $39M | $42M | $41M | $52M | $22M | $5M | $7M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $1.0K | $1.0K | |
| Paid-in Capital | $577M | $570M | $534M | $453M | $440M | $425M | $4M | $169.0K | |
| Retained Earnings | $-465M | $-487M | $-417M | $-335M | $-244M | $-118M | $-51M | $-16M | |
| AOCI | $101.0K | $24.0K | $-27.0K | $-2M | $-414.0K | $614.0K | $0 | · | |
| Stockholders' Equity | $112M | $83M | $117M | $116M | $196M | $308M | $-47M | $-16M | |
| Liabilities + Equity | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Shares Outstanding | 57,138,057 | 56,644,655 | 51,645,557 | 36,434,297 | 36,234,624 | 36,078,383 | 2,236,672 | 2,173,684 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $11M | $10M | $12M | $14M | $8M | $4M | $64.0K | |
| Restructuring | · | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $30M | $-62M | $-67M | $-85M | $-100M | $-52M | $-25M | $-8M | |
| CapEx | · | $0 | $33.0K | $192.0K | $3M | $142.0K | $21.0K | $76.0K | |
| Investing Cash Flow | $-45M | $17M | $16M | $53M | $131M | $-282M | $-21.0K | $-76.0K | |
| Stock Issued | $0 | $24M | $72M | $0 | · | · | · | · | |
| Net Stock Activity | $0 | $24M | $72M | · | · | · | · | · | |
| Financing Cash Flow | $-146.0K | $26M | $72M | $177.0K | $729.0K | $215M | $128M | $52M | |
| Net Change in Cash | $-15M | $-20M | $22M | $-32M | $31M | $-119M | $103M | $44M | |
| Free Cash Flow | · | $-62M | $-67M | $-85M | $-103M | $-52M | $-25M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.9% | · | · | · | · | · | · | · | |
| Net Margin | 31.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | 17.9% | · | · | · | · | · | · | · | |
| ROA | 16.8% | -49.5% | -52.4% | -45.1% | -43.5% | -27.6% | -33.6% | · | |
| ROE | 18.3% | -77.1% | -65.7% | -73.2% | -60.6% | -21.2% | 81.1% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 | 22.5 | 32.0 | · | |
| Quick Ratio | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 | 2.4 | 31.8 | · | |
| Interest Coverage | · | · | · | · | · | -69570.0 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | · | · | 0.0 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $1.47 | $2.26 | $3.18 | $5.41 | $8.53 | $-21.08 | · | |
| Revenue / Share | $1.22 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.51 | $-1.13 | $-1.52 | $-2.34 | $-2.77 | · | · | · | |
| Cash / Share | $0.37 | $0.64 | $1.09 | $0.94 | $1.82 | $0.96 | $69.15 | · | |
| EPS (TTM) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | · | |
| Market Cap | $139M | $121M | $145M | $66M | $193M | $1.16B | · | · | |
| P/E | 6.2 | -1.7 | -1.5 | -0.7 | -1.5 | -15.6 | · | · | |
| P/S | 2.0 | · | · | · | · | · | · | · | |
| P/B | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Tangible Book | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Cash Flow | 4.7 | -1.9 | -2.2 | -0.8 | -1.9 | -22.2 | · | · | |
| P / FCF | · | -1.9 | -2.2 | -0.8 | -1.9 | -22.1 | · | · | |
| Earnings Yield | 16.1% | -59.4% | -66.9% | -140.0% | -65.1% | -6.4% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $70M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| R&D Expense | $7M | $7M | $6M | $7M | $9M | $11M | $12M | $13M | $13M | $14M | $15M | $16M | $13M | $15M | $15M | $16M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $5M | $6M | $5M | $10M | $7M | $6M | $8M | $7M | $7M | $7M | $6M | |
| Operating Expenses | $12M | $11M | $18M | $11M | $13M | $15M | $18M | $18M | $22M | $20M | $21M | $24M | $20M | $22M | $22M | $22M | |
| Operating Income | $-12M | $-11M | $-18M | $-11M | $-13M | $55M | $-18M | $-18M | $-22M | $-20M | $-21M | $-24M | $-20M | $-22M | $-22M | $-22M | |
| Other Non-op | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $566.0K | $341.0K | $64.0K | $115.0K | $-92.0K | |
| Income Tax | · | · | · | · | $0 | $226.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-10M | $-9M | $-15M | $-8M | $-11M | $57M | $-16M | $-16M | $-20M | $-18M | $-19M | $-23M | $-19M | $-21M | $-21M | $-22M | |
| EPS (Basic) | $-0.17 | $-0.16 | $-0.27 | $-0.15 | $-0.19 | $1.00 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | |
| EPS (Diluted) | $-0.17 | $-0.16 | $-0.25 | $-0.15 | $-0.19 | $0.98 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | |
| Shares (Basic) | 57,367,283 | 57,233,413 | · | 56,929,103 | 56,803,450 | 56,663,798 | · | 56,507,956 | 55,155,220 | 51,808,849 | · | 50,943,155 | 36,516,114 | 36,483,878 | · | 36,346,181 | |
| Shares (Diluted) | 57,367,283 | 57,233,413 | · | 56,929,103 | 56,803,450 | 57,673,099 | · | 56,507,956 | 55,155,220 | 51,808,849 | · | 50,943,155 | 36,516,114 | 36,483,878 | · | 36,346,181 | |
| EBITDA | $-12M | $-11M | · | $-11M | $-13M | $55M | · | $-18M | $-22M | $-20M | · | $-24M | $-20M | $-22M | · | $-22M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $30M | $21M | $31M | $30M | $98M | $36M | $23M | $33M | $25M | $56M | $58M | $42M | $39M | $34M | $54M | |
| Prepaid Expense | $5M | $5M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $7M | |
| Current Assets | $115M | $123M | $132M | $139M | $147M | $156M | $101M | $116M | $127M | $119M | $134M | $147M | $93M | $108M | $128M | $151M | |
| PP&E (Net) | $310.0K | $338.0K | $365.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| PP&E (Gross) | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $971.0K | $885.0K | $799.0K | $738.0K | $959.0K | $845.0K | $750.0K | $710.0K | |
| Other Non-current Assets | $285.0K | $29.0K | $73.0K | $117.0K | $161.0K | $205.0K | $249.0K | $293.0K | $337.0K | · | $0 | · | · | · | · | $0 | |
| Total Assets | $125M | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | |
| Accounts Payable | $1M | $3M | $579.0K | $975.0K | $771.0K | $3M | $4M | $2M | $763.0K | $1M | $2M | $694.0K | $3M | $3M | $2M | $6M | |
| Accrued Liabilities | $14M | $12M | $15M | $15M | $16M | $14M | $17M | $19M | $18M | $16M | $17M | $14M | $11M | $10M | $13M | $15M | |
| Current Liabilities | $16M | $15M | $16M | $16M | $17M | $17M | $21M | $21M | $18M | $17M | $20M | $15M | $14M | $13M | $15M | $21M | |
| Capital Leases | $13M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $21M | $22M | $23M | $24M | $25M | $25M | $26M | |
| Total Liabilities | $29M | $29M | $31M | $32M | $34M | $35M | $39M | $40M | $39M | $38M | $42M | $38M | $38M | $37M | $41M | $47M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $580M | $578M | $577M | $576M | $574M | $572M | $570M | $568M | $567M | $540M | $534M | $533M | $458M | $455M | $453M | $450M | |
| Retained Earnings | $-484M | $-474M | $-465M | $-450M | $-441M | $-431M | $-487M | $-471M | $-456M | $-436M | $-417M | $-398M | $-375M | $-356M | $-335M | $-314M | |
| AOCI | $-68.0K | $-36.0K | $101.0K | $142.0K | $-25.0K | $-19.0K | $24.0K | $107.0K | $-115.0K | $-95.0K | $-27.0K | $-364.0K | $-661.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $96M | $104M | $112M | $126M | $133M | $142M | $83M | $97M | $111M | $104M | $117M | $134M | $82M | $98M | $116M | $133M | |
| Liabilities + Equity | $125M | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | |
| Shares Outstanding | 57,446,349 | 57,301,774 | 57,138,057 | 56,943,413 | 56,886,939 | 56,676,716 | 56,644,655 | 56,521,914 | 56,408,487 | 52,527,626 | 51,645,557 | 51,635,184 | 36,533,525 | 36,511,947 | 36,434,297 | 36,366,206 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-8M | $-10M | $-7M | $-8M | $-9M | $53M | $-15M | $-11M | $-15M | $-21M | $-14M | $-18M | $-14M | $-20M | $-22M | $-16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $33.0K | $0 | $0 | $0 | $-8.0K | |
| Investing Cash Flow | $-3M | $20M | $-3M | $9M | $-59M | $9M | $28M | $2M | $740.0K | $-14M | $12M | $-38M | $17M | $25M | $2M | $15M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-500.0K | $21M | $4M | $0 | $72M | $0 | $0 | $0 | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $4M | · | · | · | · | · | · | |
| Financing Cash Flow | $217.0K | $-185.0K | $-196.0K | $134.0K | $-116.0K | $32.0K | $291.0K | $-252.0K | $21M | $4M | $-46.0K | $72M | $0 | $51.0K | $-28.0K | $52.0K | |
| Net Change in Cash | $-11M | $9M | $-10M | $874.0K | $-68M | $62M | $13M | $-9M | $7M | $-31M | $-2M | $16M | $3M | $5M | $-20M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | · | 80.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -6.8% | -5.9% | · | -5.8% | -6.7% | 35.5% | · | -10.0% | -14.8% | -13.1% | · | -13.0% | -12.0% | -11.8% | · | -9.5% | |
| ROE | -8.7% | -7.3% | · | -7.6% | -8.7% | 46.0% | · | -13.4% | -20.6% | -18.0% | · | -17.2% | -16.3% | -15.4% | · | -12.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 8.5 | · | 8.9 | 8.7 | 9.2 | · | 5.6 | 6.9 | 7.0 | · | 9.8 | 6.7 | 8.4 | · | 7.1 | |
| Quick Ratio | 1.2 | 2.1 | · | 2.0 | 1.8 | 5.8 | · | 1.1 | 1.8 | 1.5 | · | 3.8 | 3.0 | 3.0 | · | 2.6 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.4 | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.67 | $1.82 | · | $2.22 | $2.33 | $2.50 | · | $1.72 | $1.97 | $1.99 | · | $2.60 | $2.25 | $2.69 | · | $3.66 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $1.21 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $0.93 | · | · | · | $-0.41 | · | · | · | $-0.55 | · | · | |
| Cash / Share | $0.33 | $0.52 | · | $0.54 | $0.53 | $1.74 | · | $0.41 | $0.58 | $0.48 | · | $1.12 | $1.15 | $1.07 | · | $1.48 | |
| EPS (TTM) | $-0.73 | $-0.75 | · | $0.36 | $0.23 | $0.06 | · | $-1.33 | $-1.50 | $-1.66 | · | $-2.13 | $-2.28 | $-2.39 | · | $-2.64 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $70M | $70M | $70M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-43M | $-43M | · | $21M | $14M | $5M | · | $-73M | $-81M | $-80M | · | $-84M | $-83M | $-87M | · | $-96M | |
| Market Cap | $106M | $122M | · | $216M | $141M | $88M | · | $246M | $263M | $266M | · | $148M | $184M | $69M | · | $61M | |
| P/E | -2.5 | -2.8 | · | 10.5 | 10.8 | 25.8 | · | -3.3 | -3.1 | -3.1 | · | -1.3 | -2.2 | -0.8 | · | -0.6 | |
| P/S | · | · | · | 3.1 | 2.0 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.1 | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | |
| P / Tangible Book | 1.1 | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | |
| P / Cash Flow | · | -11.9 | · | · | · | 1.6 | · | · | · | -12.6 | · | · | · | -3.4 | · | · | |
| Earnings Yield | -39.5% | -35.2% | · | 9.5% | 9.3% | 3.9% | · | -30.6% | -32.2% | -32.7% | · | -74.2% | -45.1% | -126.5% | · | -156.2% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $70M | $0 | · | · | · |
| Margen Operativo % | 17.9% | · | · | · | · |
| Beneficio neto | $22M | $-70M | $-82M | $-91M | $-126M |
| EPS Diluido | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 |
| Ratio Rápido | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-62M | $-67M | $-85M | $-103M |
Propietarios institucionales (13F) 108 declarantes · $58.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
108
Valor en tenencia
$58.9M
Nuevas posiciones
27
Posiciones cerradas
30
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 27 (+4 vs trimestre anterior) | 30 (+11 vs trimestre anterior) | 37 (+3 vs trimestre anterior) | 26 (-7 vs trimestre anterior) | -3.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| NEA Management Company, LLC | $8 230 200 | 4 448 757 | 13,97% | Acciones |
| BlackRock, Inc. | $7 246 613 | 3 917 088 | 12,30% | Acciones |
| VANGUARD GROUP INC | $5 318 922 | 2 188 857 | 9,03% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 931 750 | 2 125 270 | 6,67% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $3 630 429 | 1 962 394 | 6,16% | Acciones |
| Defilade Capital Management, L.P. | $3 098 748 | 1 674 999 | 5,26% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $2 525 486 | 1 365 384 | 4,29% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $2 254 419 | 1 218 171 | 3,83% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $2 021 837 | 1 092 885 | 3,43% | Acciones |
| AWM Investment Company, Inc. | $1 850 000 | 1 000 000 | 3,14% | Acciones |
| MARSHALL WACE, LLP | $1 658 714 | 896 602 | 2,81% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 464 153 | 791 434 | 2,48% | Acciones |
| FMR LLC | $1 190 786 | 643 668 | 2,02% | Acciones |
| Balyasny Asset Management L.P. | $1 003 018 | 542 172 | 1,70% | Acciones |
| STATE STREET CORP | $971 274 | 525 013 | 1,65% | Acciones |
| BANK OF AMERICA CORP /DE/ | $765 004 | 413 516 | 1,30% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $753 087 | 407 074 | 1,28% | Acciones |
| NORTHERN TRUST CORP | $675 979 | 365 394 | 1,15% | Acciones |
| Bank of New York Mellon Corp | $589 713 | 318 763 | 1,00% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $573 228 | 309 853 | 0,97% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $546 068 | 295 172 | 0,93% | Acciones |
| JANE STREET GROUP, LLC | $535 967 | 289 712 | 0,91% | Acciones |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $534 411 | 288 871 | 0,91% | Acciones |
| GOLDMAN SACHS GROUP INC | $534 243 | 288 780 | 0,91% | Acciones |
| STIFEL FINANCIAL CORP | $520 304 | 281 245 | 0,88% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $491 290 | 265 562 | 0,83% | Acciones |
| UBS Group AG | $490 830 | 265 313 | 0,83% | Acciones |
| Empowered Funds, LLC | $459 048 | 248 134 | 0,78% | Acciones |
| MORGAN STANLEY | $427 720 | 231 200 | 0,73% | Acciones |
| TORONTO DOMINION BANK | $395 900 | 214 000 | 0,67% | Opción de compra |
| RITHOLTZ WEALTH MANAGEMENT | $330 186 | 178 479 | 0,56% | Acciones |
| D. E. Shaw & Co., Inc. | $291 079 | 157 340 | 0,49% | Acciones |
| Invesco Ltd. | $243 577 | 131 663 | 0,41% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $199 223 | 107 688 | 0,34% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $191 660 | 103 600 | 0,33% | Acciones |
| RB Capital Management, LLC | $185 000 | 100 000 | 0,31% | Acciones |
| CITADEL ADVISORS LLC | $166 500 | 90 000 | 0,28% | Opción de compra |
| AMERICAN CENTURY COMPANIES INC | $150 425 | 81 311 | 0,26% | Acciones |
| Quadrature Capital Ltd | $141 906 | 76 706 | 0,24% | Acciones |
| Nuveen, LLC | $119 882 | 64 801 | 0,20% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $115 135 | 62 235 | 0,20% | Acciones |
| CITADEL ADVISORS LLC | $112 850 | 61 000 | 0,19% | Opción de venta |
| Graham Capital Management, L.P. | $100 329 | 54 232 | 0,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $97 865 | 52 900 | 0,17% | Opción de compra |
| DEUTSCHE BANK AG\ | $85 170 | 46 038 | 0,14% | Acciones |
| XTX Topco Ltd | $81 957 | 44 301 | 0,14% | Acciones |
| Point72 Asia (Singapore) Pte. Ltd. | $78 121 | 20 613 | 0,13% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $77 700 | 42 000 | 0,13% | Acciones |
| DLK Investment Management, LLC | $75 562 | 16 215 | 0,13% | Acciones |
| LPL Financial LLC | $75 471 | 40 795 | 0,13% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Voyageurs I Parallel, L.P., Versant Voyageurs I GP, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I GP Company, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC ×7 presentaciones | 8 de agosto de 2024 | · | Presentación inicial | · | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×2 presentaciones | 13 de mayo de 2024 | · | Presentación inicial | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah ×2 presentaciones | 9 de mayo de 2024 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 22 insiders · 10 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Mark A. Velleca | PRESIDENT & CEO | 21 de enero de 2026 A | 121 522 | 0 | 0 | $0 |
| David M. Epstein | Officer Title: President and Chief Executive Officer | 27 de junio de 2023 S | 671 423 | 0 | 0 | $0 |
| Fang Ni | Officer Title: Chief Business Officer and Chief Financial Officer | 14 de febrero de 2024 A | 125 389 | 0 | 0 | $0 |
| Thomas Leggett | Chief Financial Officer | 17 de febrero de 2021 A | 0 | 0 | 0 | $0 |
| Brent Hatzis-Schoch | Officer Title: Chief Operating Officer and General Counsel | 21 de enero de 2026 A | 83 400 | 0 | 0 | $0 |
| Erika Jones | Officer Title: Senior Vice President, Finance and Corporate Controller | 21 de enero de 2026 A | 85 150 | 0 | 0 | $0 |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | 21 de enero de 2026 A | 170 192 | 0 | 0 | $0 |
| Sergey Yurasov | CHIEF MEDICAL OFFICER | 21 de enero de 2026 A | 75 000 | 0 | 0 | $0 |
| Christopher D. Roberts | Chief Scientific Officer | 5 de abril de 2021 M | 3 200 | 0 | 0 | $0 |
| Rachel Humphrey | Chief Medical Officer | 17 de febrero de 2021 A | 10 000 | 0 | 0 | $0 |
| Prakash Raman | Consejero | 18 de septiembre de 2026 A | 51 840 | 0 | 0 | $0 |
| Ali Behbahani | Consejero | 18 de septiembre de 2026 A | 110 236 | 0 | 0 | $0 |
| Shannon Campbell | Consejero | 26 de junio de 2026 A | 8 865 | 0 | 0 | $0 |
| Samarth Kulkarni | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Garry E Menzel | Consejero | 26 de junio de 2026 A | 51 825 | 0 | 0 | $0 |
| Kapil Dhingra | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Wendy L Dixon | Consejero | 15 de marzo de 2024 A | 38 054 | 0 | 0 | $0 |
| Alexander Mayweg | Consejero | 16 de mayo de 2023 A | · | 0 | 0 | $0 |
| Rajeev Shah | Consejero | 16 de mayo de 2023 A | 0 | 0 | 0 | $0 |
| Bradley J Bolzon PhD | Consejero | 18 de junio de 2021 A | 21 851 | 0 | 0 | $0 |
| Robert Alexander Ingram | · | 16 de diciembre de 2022 A | 42 854 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | · | 3 de febrero de 2020 C | 568 185 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 16 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 158 433 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 41 055 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 3 996 SH | 2 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,01% | 369 985 SH | 11 de septiembre de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 9 610 SH | 2 de octubre de 2026 | Diario |
| DFSV · Dimensional ETF Trust | 0,00% | 210 208 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1 187 063 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 22 531 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 30 513 SH | 2 de octubre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 62 435 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 35 761 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 511 250 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 556 251 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 272 839 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 462 815 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 477 103 SH | 11 de septiembre de 2026 | Diario |
BDTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$10.00
+429,1%
5 35,7%
Compra fuerte
7 50,0%
Compra
2 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
7 analistas · 2026-09-28Objetivo medio $10.00 +429,1%
← Por Debajo de Todos los Objetivos
Precio Actual $1.89
Mín$8.00
Media$10.00
Máx$14.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 5, 2026